Vitaspring Biomedical VSBC
OTC VSBC
$0.02 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Vitaspring Biomedical (VSBC) Price to FCF (2020 - 2026)

Updated

Vitaspring Biomedical's (VSBC) Price to FCF came in at 195.90 for fiscal Q2 2027 (quarter ended Jul 31, 2026), down 60.4% from the prior quarter.

Analysis

Vitaspring Biomedical (VSBC) Price to FCF (2020 - 2026) Analysis & Trends

Since fiscal Q2 2021, Vitaspring Biomedical has reported Price to FCF for 6 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Vitaspring Biomedical 4.14 Mn 4.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 195.90
Apr 30, 2026 495.05
Jul 31, 2022 24,267.92
Apr 30, 2021 6,934.52
Oct 31, 2020 1.00 Mn
Jul 31, 2020 353,436.00
API Access

Vitaspring Biomedical Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=VSBC&period=max&api_key=YOUR_API_KEY